Contract research
organizations.
For CROs whose scientific depth shapes every sponsor conversation. Sponsor-grade thinking, made visible and defensible.

CROs already shape the science. Medical writing, biostatistics, regulatory affairs, and clinical operations teams carry deep therapeutic and operational expertise into every program. What has shifted is what sponsors now want to see of that work, and how early in the conversation.
Sponsors increasingly evaluate CROs on the design work, endpoints, eligibility, statistical strategy, not only on execution. The teams already shaping that work deserve a platform that compounds what they have learned across trials.
~65% Of CRO revenue tied to operations the design tier already shapesAI and modern infrastructure are moving from differentiator to baseline. The CRO that stays current with the tools the work runs on stays current with the work itself.
~30% Of sponsor RFPs now include explicit AI and infrastructure questionsEach engagement carries its own design specifications, formatting conventions, and review preferences. Writer and reviewer hours go to translating the same scientific depth into the shape each sponsor expects.
~30% Of design-tier hours spent translating between sponsor specifications and formatsWe change that, by putting modern infrastructure inside the work, opening a trial-design service line for the CROs not already there and by giving every bid a defensible design artifact, ready upon sponsor request.
Sized against a CRO design tier, medical writing, biostatistics, and regulatory affairs working together across roughly forty protocols a year. Baselines are unit-specific. The pattern holds across global and specialty CROs.
Gross margin uplift on the service line
~25% → ~33% · same delivery scopeSponsor queries per protocol delivered
Pooled across deployed cohorts · vs. unit baselineBid win rate on protocol-bundled RFPs
vs. prior year · same RFP volumeMedian delivery time to sponsor sign-off
Across all phases · net of sponsor review